[Development of original Russian antiarrhythmic drugs of the 3rd class].
Rozenshtraukh
L V
LV
Chazov
E I
EI
Glushkov
R G
RG
Golitsyn
S P
SP
Ruda
M Ia
MIa
Iuzhakov
S D
SD
L'vov
A I
AI
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001549:Benzamides / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use; D026902:Potassium Channel Blockers / Q000627:therapeutic use; D011690:Purkinje Fibers / Q000187:drug effects; D011817:Rabbits; D012426:Russia; D013449:Sulfonamides / Q000627:therapeutic use; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D001549:Benzamides; D010627:Phenethylamines; D026902:Potassium Channel Blockers; D013449:Sulfonamides; C067192:ibutilide; C105049:nibentan; C063533:dofetilide